These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
516 related items for PubMed ID: 8587458
1. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy. Schiffrin EL, Larivière R, Li JS, Sventek P, Touyz RM. J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458 [Abstract] [Full Text] [Related]
2. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure. Schiffrin EL, Larivière R, Li JS, Sventek P. J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521 [Abstract] [Full Text] [Related]
17. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Li JS, Turgeon A, Schiffrin EL. Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791 [Abstract] [Full Text] [Related]
18. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Li JS, Schürch W, Schiffrin EL. Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227 [Abstract] [Full Text] [Related]
19. Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats. Fareh J, Touyz RM, Schiffrin EL, Thibault G. J Mol Cell Cardiol; 2000 Apr; 32(4):665-76. PubMed ID: 10756122 [Abstract] [Full Text] [Related]
20. Role of endothelin and vasopressin in DOCA-salt hypertension. Yu M, Gopalakrishnan V, McNeill JR. Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238 [Abstract] [Full Text] [Related] Page: [Next] [New Search]